Tag: period

TULSA, OK, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Vital Energy, Inc. (NYSE: VTLE) ("Vital Energy" or the "Company") today reported second-quarter 2025 financial and operating results. Supplemental slides have been posted to the Company's website and can be found at www.vitalenergy.com. A conference call is planned for 7:30 a.m. CT, Thursday, August 7, 2025. A webcast will be available through the Company's website.

FREEHOLD, NJ, Aug. 06, 2025 (GLOBE NEWSWIRE) -- UMH Properties, Inc. (NYSE:UMH) (TASE:UMH) reported Total Income for the quarter ended June 30, 2025 of $66.6 million as compared to $60.3 million for the quarter ended June 30, 2024, representing an increase of 10%. Net Income Attributable to Common Shareholders amounted to $2.5 million or $0.03 per diluted share for the quarter ended June 30, 2025 as compared to Net Income Attributable to Common Shareholders of $527,000 or $0.01 per diluted share for the quarter ended June 30, 2024. Normalized Funds from Operations Attributable to Common Shareholders (“Normalized FFO”), was $19.5 million or $0.23 per diluted share for the quarter ended June 30, 2025, as compared to $16.8 million or $0.23 per diluted share for the quarter ended June 30, 2024.

HOUSTON, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Occidental (NYSE: OXY) today announced it has signed four agreements to divest select Permian Basin assets, generating approximately $950 million in proceeds to be used for debt reduction:

Allentown, PA, Aug. 06, 2025 (GLOBE NEWSWIRE) --

CrossAmerica Partners LP Reports Second Quarter 2025 Results

Investors can contact the law firm at no cost to learn more about recovering their losses

The global industrial hemp market size is projected to reach USD 46.41 billion by 2032 from its value of USD 8.29 billion in 2023, at a CAGR of 21.1% during the forecast period (2024- 2032), as highlighted in a report published by Zion Market Research

Transaction in Own Shares   

NEW YORK, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the District of Maryland on behalf of all persons or entities who purchased the securities of Altimmune, Inc. (“Altimmune” or the “Company”) (NASDAQ: ALT) between August 10, 2023 and June 25, 2025, both dates inclusive (the “Class Period”).